175 related articles for article (PubMed ID: 37835436)
1. Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.
Schardey J; Lu C; Neumann J; Wirth U; Li Q; Jiang T; Zimmermann P; Andrassy J; Bazhin AV; Werner J; Kühn F
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835436
[TBL] [Abstract][Full Text] [Related]
2. High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.
Björner K; Chen WN; Gannavarapu VR; Axling F; Gulyas M; Halim MA; Webb DL; Hellström PM
Ups J Med Sci; 2023; 28():. PubMed ID: 38187473
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
Front Immunol; 2021; 12():778329. PubMed ID: 34975867
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer.
Wang W; Zhang Y; Liu J; Jing H; Lu K; Wang L; Zhu T; Xu Y; Bu D; Cheng M; Liu J; Shen W; Yao J; Huang S
World J Surg Oncol; 2023 Feb; 21(1):31. PubMed ID: 36726115
[TBL] [Abstract][Full Text] [Related]
5. Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer.
Meng S; Li Y; Zang X; Jiang Z; Ning H; Li J
Cancer Cell Int; 2020; 20():95. PubMed ID: 32256204
[TBL] [Abstract][Full Text] [Related]
6. Immunoprofiling of Colitis-associated and Sporadic Colorectal Cancer and its Clinical Significance.
Soh JS; Jo SI; Lee H; Do EJ; Hwang SW; Park SH; Ye BD; Byeon JS; Yang SK; Kim JH; Yang DH; Kim SY; Myung SJ
Sci Rep; 2019 May; 9(1):6833. PubMed ID: 31048714
[TBL] [Abstract][Full Text] [Related]
7. Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis.
Yaeger R; Paroder V; Bates DDB; Capanu M; Chou J; Tang L; Chatila W; Schultz N; Hersch J; Kelsen D
Clin Colorectal Cancer; 2020 Dec; 19(4):e151-e156. PubMed ID: 32798155
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
9. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
Okami H; Ozawa N; Sohda M; Yokobori T; Osone K; Erkhem-Ochir B; Dorjkhorloo G; Shiraishi T; Okada T; Sano A; Sakai M; Miyazaki T; Ogawa H; Yao T; Oike T; Sato H; Shirabe K; Shibata A; Saeki H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686454
[TBL] [Abstract][Full Text] [Related]
10. Chronic ulcerative colitis and colorectal cancer.
Rogler G
Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
[TBL] [Abstract][Full Text] [Related]
11. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
[TBL] [Abstract][Full Text] [Related]
12. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
Hone Lopez S; Kats-Ugurlu G; Renken RJ; Buikema HJ; de Groot MR; Visschedijk MC; Dijkstra G; Jalving M; de Haan JJ
Virchows Arch; 2021 Dec; 479(6):1119-1129. PubMed ID: 34338882
[TBL] [Abstract][Full Text] [Related]
14. Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancer.
Kanno H; Miyoshi H; Yoshida N; Sudo T; Nakashima K; Takeuchi M; Nomura Y; Seto M; Hisaka T; Tanaka H; Okuda K; Akagi Y; Ohshima K
Cancer Sci; 2020 Aug; 111(8):3032-3044. PubMed ID: 32449240
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
[TBL] [Abstract][Full Text] [Related]
16. Early and Partial Reduction in CD4
Olguín JE; Medina-Andrade I; Molina E; Vázquez A; Pacheco-Fernández T; Saavedra R; Pérez-Plasencia C; Chirino YI; Vaca-Paniagua F; Arias-Romero LE; Gutierrez-Cirlos EB; León-Cabrera SA; Rodriguez-Sosa M; Terrazas LI
J Cancer; 2018; 9(2):239-249. PubMed ID: 29344269
[TBL] [Abstract][Full Text] [Related]
17. The Appendix Orchestrates T-Cell Mediated Immunosurveillance in Colitis-Associated Cancer.
Collard MK; Tourneur-Marsille J; Uzzan M; Albuquerque M; Roy M; Dumay A; Freund JN; Hugot JP; Guedj N; Treton X; Panis Y; Ogier-Denis E
Cell Mol Gastroenterol Hepatol; 2023; 15(3):665-687. PubMed ID: 36332814
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
19. Genomic characterization of colitis-associated colorectal cancer.
Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
[TBL] [Abstract][Full Text] [Related]
20. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
Fantini MC; Guadagni I
Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
